toma tebaldi

45 posts

toma tebaldi banner
toma tebaldi

toma tebaldi

@tomalistar

Katılım Ağustos 2011
121 Takip Edilen101 Takipçiler
toma tebaldi retweetledi
ANSA Trentino-AA
ANSA Trentino-AA@AnsaTrentinoAA·
Leucemia pediatrica acuta, studio individua possibile terapia. Da Università Trento e Yale, per forma che colpisce bimbi Down #ANSA ow.ly/192h106kf8n
Italiano
0
1
0
97
toma tebaldi retweetledi
RDDS-Lab
RDDS-Lab@RDDS_Lab·
Struggling with annotation in your single-cell or spatial omics analysis? Make your life easier with the Cell Marker Accordion doi.org/10.1038/s41467… Congrats to Emma Busarello, Giulia Biancon, Ilaria Cimignolo, Stephanie Halene, @tomalistar, the whole team @CIBIO_UniTrento
RDDS-Lab tweet mediaRDDS-Lab tweet media
English
1
1
0
65
toma tebaldi retweetledi
RDDS-Lab
RDDS-Lab@RDDS_Lab·
Under stress, we fold. RNA assembles in granules. Always in the same way? More complex than that: “Dissecting the stress granule RNA world: dynamics, strategies, and data” doi.org/10.1261/rna.08… Kudos @BianconGiulia , Emma Busarello, Matthew Cheng, Stephanie Halene, @tomalistar
RDDS-Lab tweet media
English
0
3
3
302
toma tebaldi retweetledi
Ranjit Bindra,MD/PhD
Ranjit Bindra,MD/PhD@ranjitbindra·
Bench-to-Bedside at the speed of Yale Science, very much enjoyed the collaboration with the @Halene_lab and we now are testing this concept in the clinic! Excellent team effort @Rana_Gbyli et al! @YaleCancer @YaleRadOnc @YaleOCR clinicaltrials.gov/ct2/show/NCT03…
Halene Lab@Halene_lab

We are very excited that our recent collaborative work with the Bindra lab @ranjitbindra is now online in @Leukemia!! "In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2"👇 1/2

English
1
8
21
0
toma tebaldi retweetledi
Halene Lab
Halene Lab@Halene_lab·
We are very excited that our recent collaborative work with the Bindra lab @ranjitbindra is now online in @Leukemia!! "In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2"👇 1/2
Rana Gbyli@Rana_Gbyli

Beyond excited to share that our paper has been published today in @LeukemiaJnl ! Here we report the results of a rigorous in vivo pre-clinical evaluation of the PARP inhibitor, olaparib, in IDH1/2-mutant MDS/AML. nature.com/articles/s4137…

English
1
5
27
0
toma tebaldi retweetledi
Yuanbin Song M.D
Yuanbin Song M.D@Dr_YuanbinSong·
Thanks all the lab members in the @Halene_lab and collaborators, without their help this work will not be done! Thanks Dr.Halene,Dr. Flavell @FlavellLab for the great mentorship and outstanding guidance for this project! Thanks Dr.Shan @LShanlab for all the help and guidances!
Halene Lab@Halene_lab

Go #RBCs! We are so excited about modeling #erythropoiesis from stem to red cell in the @FlavellLab /Halene/@LShanlab labs’ liver-cytokine humanized mice. A sophisticated model to develop and test new treatments for #blooddiseases👇 @Dr_YuanbinSong @Rana_Gbyli @YaleHematology

English
2
2
12
0
toma tebaldi retweetledi
Rana Gbyli
Rana Gbyli@Rana_Gbyli·
And we're online! So honored to have contributed to this work! Read about how liver&cytokines-humanized mice can model hu #RBCdisorders in our hot-off-the-press paper published in @ScienceMagazine 👇🏻
Halene Lab@Halene_lab

Go #RBCs! We are so excited about modeling #erythropoiesis from stem to red cell in the @FlavellLab /Halene/@LShanlab labs’ liver-cytokine humanized mice. A sophisticated model to develop and test new treatments for #blooddiseases👇 @Dr_YuanbinSong @Rana_Gbyli @YaleHematology

English
7
2
22
0

Keşfet

@RDDS_Lab @CIBIO_UniTrento @chriram97 @EPerenthaler @BianconGiulia @LabCusanelli @CellReports @MacchiPaol